MedVellum
MedVellum
Back to Library

Acute Psychosis

On This Page

Overview

Acute Psychosis

Quick Reference

Critical Alerts

  • Always rule out organic causes first: Up to 10% of "psychiatric" presentations have medical etiology
  • Delirium mimics psychosis: Fluctuating consciousness = NOT primary psychosis
  • Medical clearance is essential: Check glucose, electrolytes, tox screen, vital signs
  • Never assume "known psychiatric patient": New organic cause may be present
  • Excited delirium syndrome: Can lead to sudden death - requires immediate intervention
  • Serotonin syndrome and NMS: Life-threatening medication reactions

Key Diagnostics

TestPurposeSignificance
Fingerstick glucoseHypoglycemiaRapid, reversible cause
Vital signsFever, tachycardia, hypoxiaSuggest medical cause
Urine drug screenSubstance-induced psychosisCommon in ED setting
CMPElectrolytes, glucose, renal/hepaticMetabolic causes
TSHThyroid dysfunctionHyper/hypothyroidism
CT HeadStructural lesionsIf focal signs, first episode, altered LOC

Emergency Treatments

SituationTreatmentDose
Agitation - CooperativeOral olanzapine5-10mg PO
Agitation - UncooperativeHaloperidol + Lorazepam5mg + 2mg IM
Severe agitationDroperidol2.5-5mg IM
Behavioral emergencyKetamine4-5 mg/kg IM
Known benzodiazepine responsiveLorazepam2mg IM/IV

Definition

Overview

Acute psychosis is a syndrome characterized by a break from reality, manifesting as delusions, hallucinations, disorganized speech, or grossly disorganized/catatonic behavior. In the emergency department, the priority is ensuring safety, ruling out life-threatening organic causes, and providing appropriate pharmacological intervention.

Classification

By Etiology:

CategoryExamples
Primary PsychiatricSchizophrenia, schizoaffective, brief psychotic disorder
BipolarManic or depressive episode with psychotic features
Substance-InducedStimulants, cannabis, hallucinogens, alcohol withdrawal
Medical/OrganicDelirium, encephalitis, metabolic, structural lesions
Medication-InducedSteroids, dopamine agonists, anticholinergics

By Presentation:

  • First-episode psychosis: Initial presentation; requires thorough medical workup
  • Recurrent episode in known condition: Still requires medical screen
  • Acute-on-chronic: Exacerbation of baseline; medication non-adherence common

Epidemiology

  • Lifetime risk of psychotic disorder: 3% of population
  • Schizophrenia prevalence: 1% worldwide
  • Age of onset: Males 15-25 years; females 25-35 years
  • ED presentations: 10-15% of psychiatric emergencies involve psychosis
  • Substance-induced: 25-50% of psychosis presentations in urban EDs

Etiology

Primary Psychiatric Disorders:

  • Schizophrenia (most common chronic cause)
  • Schizoaffective disorder
  • Brief psychotic disorder (<1 month)
  • Schizophreniform (1-6 months)
  • Bipolar disorder with psychotic features
  • Major depression with psychotic features
  • Delusional disorder

Substance-Related:

SubstancePresentation
Stimulants (methamphetamine, cocaine)Paranoid delusions, tactile hallucinations
Cannabis (high-potency)Paranoid ideation, anxiety
Hallucinogens (LSD, psilocybin)Visual hallucinations, synesthesia
Alcohol withdrawalVisual hallucinations, tremor, delirium tremens
PCP/KetamineDissociation, bizarre behavior, nystagmus
Synthetic cannabinoidsAgitation, aggression, unpredictable behavior

Medical Causes (MUST Exclude):

CategoryExamples
InfectiousEncephalitis (HSV, HIV), meningitis, sepsis, UTI in elderly
MetabolicHypoglycemia, hypo/hypernatremia, hypercalcemia, uremia, hepatic encephalopathy
EndocrineThyroid storm, myxedema, adrenal crisis
NeurologicalSeizures (ictal/post-ictal), stroke, TBI, brain tumor
AutoimmuneAnti-NMDA receptor encephalitis, lupus cerebritis
ToxicCO poisoning, heavy metals, withdrawal syndromes

Pathophysiology

Neurobiological Basis

Dopamine Hypothesis:

  • Excessive dopamine activity in mesolimbic pathway → positive symptoms (hallucinations, delusions)
  • Decreased dopamine in prefrontal cortex → negative symptoms (flat affect, anhedonia)
  • Antipsychotics work primarily via D2 receptor blockade

Glutamate Hypothesis:

  • NMDA receptor hypofunction contributes to psychotic symptoms
  • Explains why PCP/ketamine (NMDA antagonists) cause psychosis

Serotonin Involvement:

  • 5-HT2A receptor activation contributes to hallucinations
  • Atypical antipsychotics have 5-HT2A antagonism

Substance-Induced Mechanisms

SubstanceMechanism
StimulantsMassive dopamine release, neurotoxicity
CannabisCB1 receptor activation, dopamine modulation
Hallucinogens5-HT2A agonism
Alcohol withdrawalGABA under-activity, glutamate excess
AnticholinergicsCholinergic blockade, delirium

Clinical Presentation

Core Psychotic Symptoms

Positive Symptoms:

SymptomDescription
DelusionsFixed false beliefs not amenable to logic
HallucinationsPerceptions without stimulus (auditory most common)
Disorganized speechTangential, loose associations, word salad
Disorganized behaviorUnusual motor behavior, inappropriate affect

Types of Delusions:

Types of Hallucinations:

Negative Symptoms (More chronic, less ED-relevant):

Agitated vs. Non-Agitated Presentation

FeatureAgitatedNon-Agitated
BehaviorCombative, threatening, pacingWithdrawn, catatonic, disorganized
RiskAcute danger to self/othersSafety risk from inability to care for self
UrgencyImmediate pharmacological interventionTime for evaluation, oral medications
Staff safetyHigh priorityLess immediate concern

Physical Examination

Vital Signs (Abnormal suggests medical cause):

Mental Status Examination:

DomainAssessment
AppearanceHygiene, clothing, motor activity
BehaviorCooperative, agitated, catatonic
SpeechRate, volume, coherence
Mood/AffectStated mood, observed affect (flat, labile)
Thought processLinear vs. disorganized, loosening
Thought contentDelusions, suicidal/homicidal ideation
PerceptionHallucinations, illusions
CognitionOrientation, attention, memory
InsightAwareness of illness
JudgmentDecision-making capacity

Neurological Examination:


Paranoid/Persecutory
Being followed, monitored, poisoned
Grandiose
Special abilities, wealth, destiny
Referential
Messages in TV, radio meant for them
Somatic
Body is infested, rotting, changed
Thought insertion/withdrawal/broadcasting
Common presentation.
Red Flags

Indicators of Medical/Organic Cause

FindingConcernAction
Altered level of consciousnessDelirium, not primary psychosisFull medical workup
Visual hallucinations predominantOrganic causeCT head, metabolic workup
Acute onset (hours)Medical causeImmediate evaluation
Age >0 first episodeOrganic etiologyExtensive medical workup
New focal neurological signsStructural lesionUrgent neuroimaging
Vital sign abnormalitiesMedical illnessAddress medical cause
Fluctuating symptomsDeliriumNot primary psychosis
Recent head traumaTBI, subduralCT head
ImmunocompromisedOpportunistic CNS infectionLumbar puncture, imaging

Psychiatric Emergencies

FindingConcernAction
Command hallucinations to harmImminent violenceSecurity, pharmacological restraint
Active suicidal ideation with planSuicide risk1:1 observation, safety measures
Catatonic stuporLethal catatoniaLorazepam trial, consider ECT
NMS features (rigidity, fever, AMS)Neuroleptic malignant syndromeStop antipsychotics, supportive care
Excited deliriumSudden death riskImmediate cooling, sedation

Differential Diagnosis

Medical Mimics of Psychosis

ConditionKey Distinguishing Features
DeliriumFluctuating attention, altered LOC, usually acute
Anti-NMDA receptor encephalitisYoung women, prodrome, movement disorder
HypoglycemiaRapid onset, diaphoresis, responds to glucose
ThyrotoxicosisTremor, weight loss, heat intolerance
Wernicke's encephalopathyAtaxia, ophthalmoplegia, confusion, alcohol use
Hepatic encephalopathyAsterixis, liver disease, elevated ammonia
Temporal lobe epilepsyIctal automatisms, post-ictal confusion
Brain tumorGradual onset, focal signs, headache
StrokeSudden onset, focal deficits
HIV encephalopathyRisk factors, opportunistic infections
SyphilisHistory, positive serology

Psychiatric Differential

ConditionKey Features
Schizophrenia> months symptoms, deteriorating function
Brief psychotic disorder<1 month, often stress-related
Bipolar maniaEuphoria, decreased sleep, grandiosity
Psychotic depressionMood congruent delusions, depression prominent
PTSD with dissociationTrauma history, flashbacks
Borderline personalityStress-related transient psychosis
MalingeringSecondary gain, inconsistent symptoms

Diagnostic Approach

Immediate Safety and Stabilization

  1. Ensure scene safety for staff and patient
  2. De-escalation techniques
  3. Physical restraints only as last resort
  4. Rapid assessment of dangerous behaviors

Medical Clearance Algorithm

All Patients:

  • Fingerstick glucose
  • Vital signs (T, HR, BP, RR, O2 sat)
  • Urine drug screen
  • Basic metabolic panel
  • Mental status examination

First Episode Psychosis or High Suspicion for Organic:

TestIndication
CBCInfection, WBC abnormalities
LFTsHepatic encephalopathy
TSHThyroid disorders
AmmoniaHepatic encephalopathy
CT HeadStructural CNS pathology
Lumbar punctureEncephalitis, meningitis
EEGSeizures, encephalopathy
HIV, syphilis serologyCNS infections
B12Deficiency psychosis
UrinalysisUTI (elderly)

Consider in Young Patients with Unusual Presentation:

  • Anti-NMDA receptor antibodies
  • Autoimmune encephalitis panel
  • MRI brain

Clinical Decision Rules

Organic vs Primary Psychiatric Psychosis:

FactorFavors OrganicFavors Primary
Age of onset>0 years15-35 years
Onset speedAcute (hours to days)Gradual (weeks to months)
ConsciousnessFluctuating/impairedClear
OrientationImpairedUsually intact
Visual hallucinationsCommonLess common
Vital signsAbnormalUsually normal
Medical historyRisk factors presentNone
Response to antipsychoticPoorGood

Treatment

Principles of Management

  1. Safety first: Staff and patient safety paramount
  2. De-escalation: Verbal techniques before medications
  3. Rule out organic causes: Medical workup
  4. Pharmacological intervention: When needed for safety
  5. Avoid unnecessary restraints: Medication preferable
  6. Least restrictive environment: When safe

De-escalation Techniques

  • Speak calmly, use patient's name
  • Maintain safe distance, avoid cornering
  • Offer choices (oral medication, sitting)
  • Remove stimuli (noise, crowds)
  • Listen to concerns, validate emotions
  • Clear communication, set limits
  • Show respect and empathy

Pharmacological Management

Oral Medications (Cooperative Patient):

MedicationDoseOnsetNotes
Olanzapine ODT5-10mg15-45 minPreferred if willing
Risperidone1-2mg30-60 minLiquid available
Lorazepam1-2mg15-30 minUndifferentiated agitation
Haloperidol5mg30-60 minOlder agent, effective

Intramuscular Medications (Uncooperative Patient):

MedicationDoseOnsetNotes
Olanzapine10mg IM15-30 minAvoid with benzodiazepines
Haloperidol + Lorazepam5mg + 2mg IM15-20 minClassic "B52" (add diphenhydramine 50mg)
Droperidol2.5-5mg IM10-20 minRapid, effective; QTc monitoring
Ziprasidone10-20mg IM15-30 minLower EPS risk
Ketamine4-5 mg/kg IM5 minSevere agitation, excited delirium

Special Situations:

ScenarioPreferred AgentRationale
Unknown etiologyLorazepamSafe if organic cause
Alcohol withdrawalBenzodiazepinesTreats underlying withdrawal
Stimulant intoxicationBenzodiazepinesAvoid antipsychotics initially
Known schizophreniaAntipsychoticAddresses underlying condition
PregnantHaloperidol or olanzapineBetter safety data
ElderlyLower doses of allStart low, go slow

Safety Considerations

  • QTc prolongation: Droperidol, haloperidol, ziprasidone
  • Respiratory depression: Benzodiazepines, especially with opioids
  • EPS/acute dystonia: Typical antipsychotics; treat with diphenhydramine/benztropine
  • NMS risk: All antipsychotics; watch for rigidity, fever
  • Don't combine IM olanzapine with benzodiazepines: Cardiorespiratory depression

Physical Restraints

  • Last resort only
  • Documentation required: Indication, less restrictive measures tried
  • Time-limited: Reassess every 15-30 minutes
  • Continuous monitoring: Vital signs, respiratory status
  • Supine positioning increases mortality: Avoid prone restraint

Disposition

Admission Criteria

Psychiatric Admission:

  • First episode psychosis requiring stabilization
  • Danger to self (suicidal ideation/behavior)
  • Danger to others (homicidal ideation/behavior)
  • Unable to care for self due to psychosis
  • Medication non-adherence requiring supervised treatment
  • Failed outpatient management

Medical Admission:

  • Identified medical cause requiring treatment
  • Uncertain etiology requiring further workup
  • NMS, serotonin syndrome, excited delirium
  • Delirium requiring ongoing evaluation

Discharge Criteria

  • Medical causes excluded or treated
  • No imminent danger to self or others
  • Able to care for basic needs
  • Support system in place
  • Outpatient follow-up arranged
  • Medication plan established

Involuntary Commitment

  • Laws vary by jurisdiction
  • Generally requires:
    • Mental illness present
    • Danger to self or others OR unable to care for self
    • Less restrictive alternatives not appropriate
  • Document clearly the specific criteria met

Follow-Up Recommendations

SituationFollow-Up
First episode psychosisPsychiatry within 1-2 days
Known patient stable on medicationsPsychiatry within 1 week
Substance-inducedPsychiatry + addiction medicine
Medication changePsychiatry within 3-5 days

Patient Education

Condition Explanation (For Families)

  • "Your family member is experiencing psychosis, which means their brain is having difficulty distinguishing what's real from what isn't."
  • "This can be caused by mental illness, substances, or physical medical conditions."
  • "With proper treatment, many people with psychosis can lead stable lives."

Medication Education

  • Explain purpose of medications
  • Common side effects to expect
  • Importance of adherence
  • Warning signs requiring return

Safety Planning

  • Remove access to weapons
  • Supervise medications
  • Have crisis numbers available
  • Develop a crisis plan

Warning Signs Requiring Return

  • Worsening symptoms
  • Refusal to eat or drink
  • Medication side effects (stiffness, fever, repetitive movements)
  • Suicidal or aggressive thoughts
  • Inability to care for self

Special Populations

Adolescents

  • First episode often presents in adolescence
  • Differentiate from substance use
  • May present with prodromal symptoms
  • Early intervention programs improve outcomes
  • Involve family when possible

Elderly

  • Always assume organic cause until proven otherwise
  • Delirium extremely common
  • Lower doses of all medications
  • UTI is common trigger for altered mental status
  • Anticholinergic effects more pronounced
  • Increased sensitivity to antipsychotics

Pregnant Patients

  • Teratogenicity considerations
  • Haloperidol has longest safety record
  • Olanzapine, risperidone relatively safe
  • Avoid valproate, carbamazepine
  • Involve obstetrics
  • Untreated psychosis risks outweigh medication risks

Patients with Intellectual Disability

  • May have difficulty communicating symptoms
  • Baseline behavior important from caregivers
  • Lower threshold for medical workup
  • Adjust communication style
  • Consider nonverbal signs of distress

Substance Use Disorder Comorbidity

  • Extremely common (50% of schizophrenia patients)
  • Complicates treatment
  • May need dual diagnosis program
  • Risk of withdrawal syndromes

Quality Metrics

Performance Indicators

MetricTargetRationale
Time to de-escalation attempt100%Safety outcome
Medical clearance completed100%Avoid missing organic cause
Glucose checked before antipsychotic100%Avoid treating hypoglycemia with sedation
Restraint use rateMinimizeLess restrictive care
Time in restraints<30 minPatient dignity and safety
Substance screen completed>0%Identify substance-induced causes

Documentation Requirements

  • Safety assessment (SI/HI documented)
  • Medical clearance workup and results
  • Mental status examination
  • De-escalation attempts
  • Medication administration times and effects
  • Restraint justification if used
  • Capacity assessment
  • Disposition decision and rationale
  • Follow-up arrangements

Key Clinical Pearls

Diagnostic Pearls

  • "All psychosis is organic until proven otherwise": Always medical workup
  • Fluctuating consciousness = delirium, not psychosis: Key distinction
  • Visual hallucinations suggest organic cause: Be suspicious
  • First episode over 40 = medical etiology likely: Extensive workup
  • "Drug screen negative" doesn't exclude substance use: Synthetic drugs may not be detected
  • Anti-NMDA encephalitis: Think of in young women with psychiatric + movement signs

Treatment Pearls

  • De-escalation first: Often effective and safer
  • Offer oral before IM: Less traumatic, builds rapport
  • Benzodiazepines if unsure of etiology: Safe for organic causes
  • Avoid IM olanzapine + IM benzodiazepine together: Cardiorespiratory depression
  • 5-10-15-20 rule: Reassess effect every 15-20 minutes before re-dosing
  • "Start low, go slow" in elderly: Paradoxical worsening possible

Disposition Pearls

  • Psychiatric hold criteria vary by state: Know your local laws
  • Document danger clearly: Specific behaviors and statements
  • Family involvement improves outcomes: Engage when appropriate
  • Outpatient follow-up is essential: Arrange before discharge
  • Substance-induced psychosis: Resolves with abstinence but may unmask primary disorder

References
  1. Nordstrom K, et al. Medical Evaluation and Triage of the Agitated Patient: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Medical Evaluation Workgroup. West J Emerg Med. 2012;13(1):3-10.
  2. Wilson MP, et al. The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. West J Emerg Med. 2012;13(1):26-34.
  3. Garriga M, et al. Assessment and management of agitation in psychiatry: Expert consensus. World J Biol Psychiatry. 2016;17(2):86-128.
  4. Marder SR. First-episode psychosis. UpToDate. 2024.
  5. Correll CU, et al. Efficacy and safety of intramuscular aripiprazole in adult patients with acute agitation. J Clin Psychiatry. 2019;80(1).
  6. NICE Guideline. Violence and aggression: short-term management in mental health, health and community settings. 2015.
  7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). 2013.
  8. Zun LS. Evidence-based review of pharmacotherapy for acute agitation. Part 1: Onset of efficacy. J Emerg Med. 2018;54(3):364-374.

At a Glance

EvidenceStandard
Last UpdatedRecently

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines